Ana Checa-Ros

15PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsMolecular targetsNutrigenomics and personalised nutritionNeurogeneticsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 13, 2026
The Effects of GLP-1RA-Based and SGLT2 Inhibitor Therapy on Perirenal Adipose Tissue in CKD Patients.

|May 27, 2026
Depot-Specific Cardiorenal Adipose Remodeling with SGLT2i in Chronic Kidney Disease.

|Feb 27, 2026
Preliminary Real-World Experience with Semaglutide in Obese Patients with Type 2 Diabetes on Chronic Hemodialysis: A Multicenter Pilot Study.

Alejandra Yugueros, Luis D'Marco, Alejandro Valero

|Feb 26, 2026
Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria.

Ana Checa-Ros, Owahabanun Joshua Okojie, Jacob Gabriel Wassouf

|Sep 13, 2025
Novel Pathogenic Genotype in SLC12A3 Associated to Gitelman Syndrome: A Case Report.

Patricia Tomás-Simó, Antonio Sierra-Rivera, Ana Checa-Ros

|Aug 27, 2025
SGLT2 Inhibitors: Multifaceted Therapeutic Agents in Cardiometabolic and Renal Diseases.

Ana Checa-Ros, Owahabanun-Joshua Okojie, Luis D'Marco

Pageof 3

Frequent Collaborators

11 joint publications

Luis D'Marco

3 joint publications

Antonio Molina-Carballo

3 joint publications

Valmore Bermúdez

3 joint publications

Owahabanun-Joshua Okojie